News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,777 Results
Type
Article (42707)
Company Profile (312)
Press Release (698738)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (208243)
Career Advice (2077)
Deals (35989)
Drug Delivery (132)
Drug Development (82613)
Employer Resources (177)
FDA (16622)
Job Trends (15214)
News (352120)
Policy (33230)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2638)
Accelerated approval (43)
Adcomms (25)
Allergies (171)
Alliances (50738)
ALS (200)
Alzheimer's disease (1776)
Antibody-drug conjugate (ADC) (412)
Approvals (16968)
Artificial intelligence (627)
Autoimmune disease (239)
Automation (52)
Bankruptcy (365)
Best Places to Work (11761)
BIOSECURE Act (21)
Biosimilars (209)
Biotechnology (212)
Bladder cancer (179)
Brain cancer (67)
Breast cancer (704)
Cancer (5541)
Cardiovascular disease (453)
Career advice (1763)
Career pathing (41)
CAR-T (312)
CDC (54)
Celiac Disease (2)
Cell therapy (832)
Cervical cancer (43)
Clinical research (71297)
Collaboration (2012)
Company closure (4)
Compensation (1323)
Complete response letters (74)
COVID-19 (2764)
CRISPR (104)
C-suite (1051)
Cystic fibrosis (150)
Data (7356)
Decentralized trials (3)
Denatured (26)
Depression (159)
Dermatology (70)
Diabetes (559)
Diagnostics (6952)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (310)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (268)
Earnings (91846)
Editorial (64)
Employer branding (21)
Employer resources (156)
Events (122266)
Executive appointments (1068)
FDA (20168)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1685)
Gene editing (220)
Generative AI (58)
Gene therapy (682)
GLP-1 (1040)
Government (4763)
Grass and pollen (6)
Guidances (401)
Healthcare (19172)
HIV (77)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (277)
Immuno-oncology (89)
Indications (165)
Infectious disease (3095)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (133)
Intellectual property (281)
Interviews (321)
IPO (16819)
IRA (50)
Job creations (3773)
Job search strategy (1471)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (559)
Leadership (36)
Legal (8061)
Liver cancer (98)
Longevity (30)
Lung cancer (738)
Lymphoma (414)
Machine learning (55)
Management (59)
Manufacturing (972)
MASH (178)
Medical device (14030)
Medtech (14112)
Mergers & acquisitions (20362)
Metabolic disorders (1445)
mRNA (183)
Multiple sclerosis (180)
NASH (17)
Neurodegenerative disease (393)
Neuropsychiatric disorders (98)
Neuroscience (3219)
Neurotech (1)
NextGen: Class of 2026 (6628)
Non-profit (4571)
Now hiring (74)
Obesity (685)
Opinion (291)
Ovarian cancer (197)
Pain (239)
Pancreatic cancer (273)
Parkinson's disease (352)
Partnered (33)
Patents (567)
Patient recruitment (624)
Peanut (63)
People (60706)
Pharmaceutical (64)
Pharmacy benefit managers (32)
Phase 1 (22315)
Phase 2 (31429)
Phase 3 (23242)
Pipeline (7511)
Policy (312)
Postmarket research (2585)
Preclinical (9525)
Press Release (71)
Prostate cancer (284)
Psychedelics (49)
Radiopharmaceuticals (314)
Rare diseases (1017)
Real estate (6156)
Recruiting (73)
Regulatory (25444)
Reports (56)
Research institute (2459)
Resumes & cover letters (359)
Rett syndrome (34)
RNA editing (18)
RSV (88)
Schizophrenia (168)
Series A (280)
Series B (212)
Service/supplier (11)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (164)
Sponsored (46)
Startups (3743)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (89)
The Weekly (65)
Vaccines (1076)
Venture capital (102)
Weight loss (441)
Women's health (114)
Worklife (20)
Date
Today (99)
Last 7 days (674)
Last 30 days (2485)
Last 365 days (30630)
2026 (9322)
2025 (30673)
2024 (35717)
2023 (40521)
2022 (51753)
2021 (56253)
2020 (54699)
2019 (47219)
2018 (35590)
2017 (32760)
2016 (32274)
2015 (38252)
2014 (32003)
2013 (27065)
2012 (29342)
2011 (30016)
2010 (28078)
Location
Africa (776)
Alabama (91)
Alaska (7)
Arizona (340)
Arkansas (15)
Asia (40833)
Australia (6871)
California (12642)
Canada (3601)
China (1289)
Colorado (541)
Connecticut (548)
Delaware (377)
Europe (89620)
Florida (1886)
Georgia (414)
Hawaii (3)
Idaho (63)
Illinois (1025)
India (86)
Indiana (578)
Iowa (23)
Japan (509)
Kansas (133)
Kentucky (47)
Louisiana (38)
Maine (75)
Maryland (1519)
Massachusetts (9068)
Michigan (352)
Minnesota (693)
Mississippi (6)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (137)
New Hampshire (84)
New Jersey (3358)
New Mexico (31)
New York (3333)
North Carolina (1623)
North Dakota (9)
Northern California (6281)
Ohio (375)
Oklahoma (23)
Oregon (41)
Pennsylvania (2552)
Puerto Rico (28)
Rhode Island (50)
South America (1155)
South Carolina (82)
South Dakota (2)
Southern California (4966)
Tennessee (203)
Texas (1993)
United States (44833)
Utah (383)
Vermont (1)
Virginia (298)
Washington D.C. (80)
Washington State (1026)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
741,777 Results for "ixcells biotechnologies usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
April 17, 2026
·
5 min read
Press Releases
iXCells Biotechnologies Selected to Perform the First Pilot in Patient-Led ALS Precision Medicine Effort
August 26, 2025
·
5 min read
Press Releases
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
February 26, 2026
·
3 min read
Biotech Beach
iXCells Biotechnologies Announces Grand Opening and 2024 Rare Disease Month Workshop
iXCells Biotechnologies USA, Inc. announced the grand opening celebration of its new San Diego headquarters and Rare Disease Month Workshop.
February 1, 2024
·
3 min read
Press Releases
iXCells Biotechnologies Launches iPSCore™ Platform for Generating Highly Characterized iPSC-derived Human Cell Models
June 12, 2025
·
4 min read
Business
iXCells Biotechnologies Strengthens Leadership Team; Welcomes New CEO
iXCells Biotechnologies USA, Inc., a cell technology company specializing in providing cell-based products and drug discovery service solutions to the global academic, biotech, pharmaceutical, and rare disease communities, announced the appointment of Helge Bastian, PhD, as the company’s new Chief Executive Officer.
January 18, 2024
·
4 min read
Press Releases
Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation
March 30, 2026
·
3 min read
Press Releases
Autonomix Medical to Present at LSI USA ’26
March 11, 2026
·
3 min read
Biotech Beach
iXCells Biotechnologies Expands Operations; New Website Goes Live
iXCells Biotechnologies USA, Inc., a cell technology company specializing in providing cell-based products and drug discovery solutions to the global academic, biotech and pharmaceutical communities, announced completing key growth initiatives.
September 6, 2023
·
2 min read
Press Releases
Aclarion CEO Brent Ness to Attend LSI USA 2026
March 12, 2026
·
3 min read
1 of 74,178
Next
